These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19632837)

  • 1. Benzo[d]imidazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1)--Hit to Lead studies.
    Wan H; Huynh T; Pang S; Geng J; Vaccaro W; Poss MA; Trainor GL; Lorenzi MV; Gottardis M; Jayaraman L; Purandare AV
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5063-6. PubMed ID: 19632837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1).
    Huynh T; Chen Z; Pang S; Geng J; Bandiera T; Bindi S; Vianello P; Roletto F; Thieffine S; Galvani A; Vaccaro W; Poss MA; Trainor GL; Lorenzi MV; Gottardis M; Jayaraman L; Purandare AV
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2924-7. PubMed ID: 19419866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,2-Diamines as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1).
    Therrien E; Larouche G; Manku S; Allan M; Nguyen N; Styhler S; Robert MF; Goulet AC; Besterman JM; Nguyen H; Wahhab A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6725-32. PubMed ID: 19836951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent, Selective, and Cell Active Protein Arginine Methyltransferase 5 (PRMT5) Inhibitor Developed by Structure-Based Virtual Screening and Hit Optimization.
    Mao R; Shao J; Zhu K; Zhang Y; Ding H; Zhang C; Shi Z; Jiang H; Sun D; Duan W; Luo C
    J Med Chem; 2017 Jul; 60(14):6289-6304. PubMed ID: 28650658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of (2-(Benzyloxy)phenyl)methanamine Derivatives as Potent and Selective Inhibitors of CARM1 for the Treatment of Melanoma.
    Liu Z; Lin M; Liu C; Chen X; Chen Q; Li X; Wu X; Wang Y; Wang L; Yang F; Luo C; Jin J; Ye F
    J Med Chem; 2024 Apr; 67(8):6313-6326. PubMed ID: 38574345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.
    Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1).
    Purandare AV; Chen Z; Huynh T; Pang S; Geng J; Vaccaro W; Poss MA; Oconnell J; Nowak K; Jayaraman L
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4438-41. PubMed ID: 18619839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Studies Provide New Insights into the Role of Lysine Acetylation on Substrate Recognition by CARM1 and Inform the Design of Potent Peptidomimetic Inhibitors.
    Zhang Y; Marechal N; van Haren MJ; Troffer-Charlier N; Cura V; Cavarelli J; Martin NI
    Chembiochem; 2021 Dec; 22(24):3469-3476. PubMed ID: 34569136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Inhibitors against Coactivator Associated Arginine Methyltransferase 1 Based on Virtual Screening and Biological Assays.
    Ye F; Zhang W; Lu W; Xie Y; Jiang H; Jin J; Luo C
    Biomed Res Int; 2016; 2016():7086390. PubMed ID: 27872854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Design and Synthesis of Selective PRMT4 Inhibitors: A New Chemotype for Development of Cancer Therapeutics*.
    Sutherland M; Li A; Kaghad A; Panagopoulos D; Li F; Szewczyk M; Smil D; Scholten C; Bouché L; Stellfeld T; Arrowsmith CH; Barsyte D; Vedadi M; Hartung IV; Steuber H; Britton R; Santhakumar V
    ChemMedChem; 2021 Apr; 16(7):1116-1125. PubMed ID: 33513288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel PRMT1 inhibitors and investigation of their binding preferences using molecular modelling.
    Yang H; Ouyang Y; Ma H; Cong H; Zhuang C; Lok WT; Wang Z; Zhu X; Sun Y; Hong W; Wang H
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4635-4642. PubMed ID: 28927791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compounds.
    Njoroge FG; Vibulbhan B; Rane DF; Bishop WR; Petrin J; Patton R; Bryant MS; Chen KJ; Nomeir AA; Lin CC; Liu M; King I; Chen J; Lee S; Yaremko B; Dell J; Lipari P; Malkowski M; Li Z; Catino J; Doll RJ; Girijavallabhan V; Ganguly AK
    J Med Chem; 1997 Dec; 40(26):4290-301. PubMed ID: 9435898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1.
    Ran T; Li W; Peng B; Xie B; Lu T; Lu S; Liu W
    J Chem Inf Model; 2019 Jan; 59(1):522-534. PubMed ID: 30607947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations.
    Zhu K; Jiang C; Tao H; Liu J; Zhang H; Luo C
    Bioorg Med Chem Lett; 2018 May; 28(9):1476-1483. PubMed ID: 29628326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel 3,5-bis(bromohydroxybenzylidene)piperidin-4-ones as coactivator-associated arginine methyltransferase 1 inhibitors: enzyme selectivity and cellular activity.
    Cheng D; Valente S; Castellano S; Sbardella G; Di Santo R; Costi R; Bedford MT; Mai A
    J Med Chem; 2011 Jul; 54(13):4928-32. PubMed ID: 21612300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-based design, synthesis and biological evaluation of novel anthra[1,2-d]imidazole-6,11-dione homologues as potential antitumor agents.
    Chen TC; Yu DS; Huang KF; Fu YC; Lee CC; Chen CL; Huang FC; Hsieh HH; Lin JJ; Huang HS
    Eur J Med Chem; 2013 Nov; 69():278-93. PubMed ID: 24051300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological activity of 4-(4-benzyloxy)phenoxypiperidines as selective and reversible LSD1 inhibitors.
    Xi J; Xu S; Zhang L; Bi X; Ren Y; Liu YC; Gu Y; Xu Y; Lan F; Zha X
    Bioorg Chem; 2018 Aug; 78():7-16. PubMed ID: 29524666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas.
    Vaswani RG; Gehling VS; Dakin LA; Cook AS; Nasveschuk CG; Duplessis M; Iyer P; Balasubramanian S; Zhao F; Good AC; Campbell R; Lee C; Cantone N; Cummings RT; Normant E; Bellon SF; Albrecht BK; Harmange JC; Trojer P; Audia JE; Zhang Y; Justin N; Chen S; Wilson JR; Gamblin SJ
    J Med Chem; 2016 Nov; 59(21):9928-9941. PubMed ID: 27739677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors.
    Granchi C; Rizzolio F; Palazzolo S; Carmignani S; Macchia M; Saccomanni G; Manera C; Martinelli A; Minutolo F; Tuccinardi T
    J Med Chem; 2016 Nov; 59(22):10299-10314. PubMed ID: 27809504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors.
    Zhu K; Song JL; Tao HR; Cheng ZQ; Jiang CS; Zhang H
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3693-3699. PubMed ID: 30366617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.